The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart Disease

Lucà et al. (Tue,) reported a other. A multidisciplinary approach to GLP-1 receptor agonists and SGLT2 inhibitors marks a new era in cardiometabolic care for patients with diabetes and heart disease.